Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001192 · ClinicalTrials.gov registry record
Neuropsychological Evaluation of Psychiatric and Neurological Patients
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 4,300
- Enrollment target
NCT00001192: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00001192 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 4,300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001192 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 4,300 participants
- Enrollment target
Study Summary
This study will allow researchers to use various types of tests to evaluate cognitive and sensory functions. These tests, referred to as "batteries" will evaluate attention, executive functions, general intellectual functioning, language, memory, motor functions, orientation, personality, selected sensory and perceptual functions, vigilance (alertness), and visual-spatial functions. Children and adult patient will receive different test batteries. The goals of this research study are to; 1. Create descriptions based on the performance of each patient on the test batteries. Then use this information to relate patient behavior to their neurophysiological, neuroradiological, and biochemical descriptions. 2. Define subgroups of patients based on their neurobehavior in order to decrease the variability of psychiatric diagnoses, treatments, and prognoses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,300 participants |
| Start Date | 1983-10-18 |
| Est. Completion | 2006-12-20 |
What the finished NCT00001192 record still lists
NCT00001192 is an observational study that tracks outcomes without assigning an intervention. Its 4,300 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001192 about?
NCT00001192 is a clinical study titled "Neuropsychological Evaluation of Psychiatric and Neurological Patients". This study will allow researchers to use various types of tests to evaluate cognitive and sensory functions. These tests, referred to as "batteries" will evaluate attention, executive functions, general intellectual functioning, language, memory, motor functions, orientation, personality, selected s...
What is the current status of trial NCT00001192?
This trial is currently completed. The enrollment target is 4,300 participants. The study started on 1983-10-18. Estimated completion is 2006-12-20.
Who is sponsoring clinical trial NCT00001192?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT06492616 · 4,220 participants · Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI